Table 2.

Acoustic contrast-enhancement kinetic parameters assessed

Patient ID	Histologic diagnosis	DCE-US
		TOF (s)	TTP (s)	FT (s)
A. Malignant lesions
1	Metastasis (renal cell cancer)	13	21	8
2	Sarcoma	22	32	10
3	Liposarcoma	23	40	17
4	Sarcoma	34	57	23
5	Synovial sarcoma	12	20	8
6	Fibromyxoid sarcoma	24	35	11
7	Lymphoma	21	33	12
	Mean	21.3	34	12.7
	Standard deviation	7.4	12.5	5.5
B. Benign lesions
8	Schwannoma	29	38	9
9	Schwannoma	35	48	13
10	Schwannoma	26	42	16
11	Angioleiomyoma	50	75	25
12	Lipoma	23	50	27
13	Lipoma	27	45	18
14	Lipoma	24	50	26
	Mean	30.6	49.7	19.1
	Standard deviation	9.4	12	7
C. Malignant lesions and schwannomas
1	Metastasis (renal cell cancer)	13	21	8
2	Sarcoma	22	32	10
3	Liposarcoma	23	40	17
4	Sarcoma	34	57	23
5	Synovial sarcoma	12	20	8
6	Fibromyxoid sarcoma	24	35	11
7	Lymphoma	21	33	12
8	Schwannoma	29	38	9
9	Schwannoma	35	48	13
10	Schwannoma	26	42	16
	Mean	22.9	36.6	12.7
	Standard deviation	7.7	11.3	4.8
D. Separate analyses of schwannomas and other benign lesions
11	Angioleiomyoma	50	75	25
12	Lipoma	23	50	27
13	Lipoma	27	45	18
14	Lipoma	24	50	26
	Mean	31	55	24
	Standard deviation	9.4	12	7
8	Schwannoma	29	38	9
9	Schwannoma	35	48	13
10	Schwannoma	26	42	16
	Mean	30	42.7	12.7
	Standard deviation	4.6	5	3.5